Evermay Wealth Management LLC Has $31,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Posted by Defense World Staff on Mar 27th, 2023

Evermay Wealth Management LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 103.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 118 shares of the medical equipment provider’s stock after buying an additional 60 shares during the period. Evermay Wealth Management LLC’s holdings in Intuitive Surgical were worth $31,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 29,283,566 shares of the medical equipment provider’s stock worth $5,488,912,000 after buying an additional 282,881 shares in the last quarter. BlackRock Inc. raised its holdings in shares of Intuitive Surgical by 5.6% during the 3rd quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider’s stock worth $5,227,284,000 after buying an additional 1,477,885 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Intuitive Surgical by 3.3% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider’s stock worth $5,156,788,000 after buying an additional 816,066 shares in the last quarter. State Street Corp raised its holdings in shares of Intuitive Surgical by 0.3% during the 2nd quarter. State Street Corp now owns 15,220,507 shares of the medical equipment provider’s stock worth $3,054,908,000 after buying an additional 38,293 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in Intuitive Surgical by 1.8% in the 2nd quarter. Brown Advisory Inc. now owns 3,232,385 shares of the medical equipment provider’s stock worth $648,774,000 after purchasing an additional 58,190 shares in the last quarter. Institutional investors and hedge funds own 81.96% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP David J. Rosa sold 45,025 shares of the stock in a transaction that occurred on Monday, February 6th. The stock was sold at an average price of $250.53, for a total transaction of $11,280,113.25. Following the completion of the sale, the executive vice president now directly owns 125,385 shares of the company’s stock, valued at $31,412,704.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, EVP David J. Rosa sold 45,025 shares of the stock in a transaction on Monday, February 6th. The stock was sold at an average price of $250.53, for a total transaction of $11,280,113.25. Following the completion of the transaction, the executive vice president now directly owns 125,385 shares of the company’s stock, valued at $31,412,704.05. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 1,253 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $228.47, for a total value of $286,272.91. Following the transaction, the executive vice president now directly owns 1,950 shares of the company’s stock, valued at $445,516.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 82,396 shares of company stock valued at $20,438,478. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Up 4.9 %

Shares of Intuitive Surgical stock opened at $256.42 on Monday. The company has a market cap of $89.81 billion, a PE ratio of 70.06, a price-to-earnings-growth ratio of 5.10 and a beta of 1.29. Intuitive Surgical, Inc. has a 52 week low of $180.07 and a 52 week high of $308.97. The business has a 50 day moving average price of $242.51 and a 200-day moving average price of $240.03.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.02). The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.66 billion. Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the company earned $1.30 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.17 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Raymond James upped their target price on Intuitive Surgical from $255.00 to $270.00 and gave the stock an “outperform” rating in a report on Thursday, January 26th. Truist Financial lowered their target price on Intuitive Surgical from $310.00 to $300.00 and set a “buy” rating for the company in a report on Wednesday, January 25th. Mizuho lowered their target price on Intuitive Surgical from $245.00 to $240.00 in a report on Wednesday, January 25th. StockNews.com initiated coverage on Intuitive Surgical in a report on Thursday, March 16th. They issued a “hold” rating for the company. Finally, Citigroup reduced their price target on Intuitive Surgical from $318.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, January 25th. Six investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $269.94.

Intuitive Surgical Profile

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.